(-)-Cercosporamide CHEMBL475816 BDBM50256734
- Furukawa, A; Arita, T; Satoh, S; Araki, K; Kuroha, M; Ohsumi, J (-)-Cercosporamide derivatives as novel antihyperglycemic agents. Bioorg Med Chem Lett 19: 724-6 (2009)
- Furukawa, A; Arita, T; Satoh, S; Wakabayashi, K; Hayashi, S; Matsui, Y; Araki, K; Kuroha, M; Ohsumi, J Discovery of a novel selective PPARgamma modulator from (-)-Cercosporamide derivatives. Bioorg Med Chem Lett 20: 2095-8 (2010)
- Furukawa, A; Arita, T; Fukuzaki, T; Mori, M; Honda, T; Satoh, S; Matsui, Y; Wakabayashi, K; Hayashi, S; Nakamura, K; Araki, K; Kuroha, M; Tanaka, J; Wakimoto, S; Suzuki, O; Ohsumi, J Synthesis and biological evaluation of novel (-)-Cercosporamide derivatives as potent selective PPAR¿ modulators. Eur J Med Chem 54: 522-33 (2012)
- Dao, VH; Ourliac-Garnier, I; Bazin, MA; Jacquot, C; Baratte, B; Ruchaud, S; Bach, S; Grovel, O; Le Pape, P; Marchand, P Benzofuro[3,2-d]pyrimidines inspired from cercosporamide CaPkc1 inhibitor: Synthesis and evaluation of fluconazole susceptibility restoration. Bioorg Med Chem Lett 28: 2250-2255 (2018)
- Furukawa, A; Arita, T; Fukuzaki, T; Satoh, S; Mori, M; Honda, T; Matsui, Y; Wakabayashi, K; Hayashi, S; Araki, K; Ohsumi, J Substituents at the naphthalene C3 position of (-)-Cercosporamide derivatives significantly affect the maximal efficacy as PPAR¿ partial agonists. Bioorg Med Chem Lett 22: 1348-51 (2012)